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Completion duplex ultrasound predicts early graft
thrombosis after crural bypass in patients with
critical limb ischemia
Salvatore T. Scali, MD,a Adam W. Beck, MD,a Brian W. Nolan, MD,b,c David H. Stone, MD,b
Randall R. De Martino, MD,b Catherine K. Chang, MD,a Eva M. Rzucidlo, MD,b and
Daniel B. Walsh, MD,b Gainesville, Fla; and Lebanon, NH
Objective: To determine if intraoperative distal graft end-diastolic velocity (EDV) using completion duplex ultrasound
(CDU) predicts patency of crural bypass in patients with critical limb ischemia (CLI).
Methods: Records of 116 non-consecutive patients who underwent crural revascularization with vein conduit and CDU
between 1998 and 2008 were reviewed. Bypass grafts were performed for rest pain (34%) or tissue loss (66%), while 56%
of the reported cases were categorized as “disadvantaged” because of compromised vein quality or diseased arterial outflow. A
10-MHz low-profile transducer was used to image the entire bypass at case completion. Technical adequacy of the grafts was
verified by absence of retained valves, arteriovenous fistulas, or localized velocity increases and presence of bypass-dependent
distal pulses. Modified Rutherford scores were calculated as surrogate markers of runoff resistance and compared to distal graft
EDV. The primary study end point was graft patency during a 1-year posttreatment period. Patency rates were determined
using Kaplan-Meier life table methodology and compared using the log-rank test. Predictors of graft patency were determined
by Cox proportional hazards.
Results: Primary, primary-assisted, and secondary patency for all crural bypasses were 62%, 66%, and 70% at 1 year,
respectively. When stratified by tertiles of distal graft EDV (0 -<5 cm/s, 5-15 cm/s,>15 cm/s), 1-year primary patency
rates were 32%, 64%, and 84% (P  .001). Low (0 - < 5 cm/s) distal graft EDV (hazard ratio [HR], 3.3 confidence
interval [CI], 1.74-6.41; P < .001), poor-quality conduit (HR, 2.5; CI, 1.19-5.21; P  .016), age <70 (HR, 2.08; CI,
1.06-4.00; P  .031), and lack of statin use (HR, 2.04; CI, 1.04-4.00; P  .038) were independent predictors of graft
failure. While the modified Rutherford score correlated with distal graft EDV (P  .05), it was not an independent
predictor of patency (P  .58). Predictors of low EDV (<5 cm/s) included single-vessel runoff (odds ratio [OR], 3.33;
CI, 1.14-9.71; P  .027), poor conduit (OR, 2.94; CI, 1.16-7.41; P  0.024), and diabetes (OR, 2.86; CI, 1.14-7.21;
P  .025).
Conclusions: Distal graft EDV predicts crural vein graft patency in patients with CLI. Grafts with EDV <5 cm/s remain
at high risk for early failure. The impacts on patency of statins, age, and poor-quality conduit are, again, confirmed. These
results highlight the value of EDV using intraoperative CDU for anticipating and, possibly, improving results of open
crural revascularization. (J Vasc Surg 2011;54:1006-10.)
h
a
l
a
c
a
f
t
a
D
t
a
w
t
c
g
a
o
sOpen infrainguinal arterial reconstruction remains an
important component of contemporary vascular surgical
practice despite the advent of endoluminal therapies.1-3
Patients with critical limb ischemia (CLI) often require
crural revascularization due to complex, multilevel occlu-
sive lesions with anatomy unfavorable for percutaneous
therapies. Early graft failure in this population remains a
predictor of major adverse outcomes, including subsequent
interventions, limb loss, and death.4,5 A variety of reports
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1006ave previously demonstrated the utility of intraoperative
nd postoperative infrainguinal vein graft duplex surveil-
ance in an attempt to enhance graft performance and
ugment limb preservation.6,7
Early graft failure historically has been attributed to
haracteristics of the patient, the conduit, and the target
rtery.8 Ideally, the time to identify and modify these
actors is prior to or at operation to avoid graft revision or
hrombosis.7 Using completion duplex ultrasound (CDU),
number of hemodynamic parameters can be measured.
istal graft end-diastolic velocity (EDV) has been reported
o be a predictor of early infrainguinal graft failure.9 In
ddition, Johnson et al identified a subgroup of patients
ith technically adequate grafts with low-flow (peak sys-
olic velocity [PSV], 45 cm/s) and high peripheral vas-
ular resistance (PVR, ie, no diastolic flow in the distal
raft; EDV  0), and proposed that such bypasses be
ggressively treated with adjunctive procedures or chronic
ral anticoagulation.7
In an effort to review our results and further identify a
ubgroup of crural grafts at risk of early thrombosis, we
erformed a review of all tibial level bypasses constructed
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Volume 54, Number 4 Scali et al 1007for CLI with autogenous vein that underwent CDU at our
institution. Additionally, patient and procedure-specific
factors were analyzed in an attempt to define predictors of
graft patency and limb salvage.
METHODS
A retrospective review of 116 non-consecutive crural
level vein bypass grafts that underwent intraoperative CDU
from 1998 to 2008 was performed after approval was
obtained from the institution’s committee for the protec-
tion of human subjects. Patient demographics, CDU he-
modynamics, post-operative reintervention/reoperation,
antiplatelet and anticoagulant use, and major amputation
were recorded. All patients suffered CLI (Rutherford class
IV or V). All bypass grafts were primary tibial or pedal artery
reconstructions. Preoperative vein mapping was completed
in all patients with duplex imaging to ascertain the quality,
diameter, and length of autogenous conduit available. Sixty
percent of patients who underwent CDUwere those of two
senior authors (E.M.R., D.B.W.) who use CDU as their
primary method of confirming technical adequacy. Al-
though in situ configurations were used preferentially for
arterial reconstruction, nonreversed and reversed saphe-
nous vein, composite vein, or arm vein were utilized. Sa-
phenous vein quality was recorded based on surgeon assess-
ment as described in the operative report. All veins were
assessed by the surgeons for quality as conduits at opera-
tion. Veins were considered poor quality most frequently
based on the presence of syncytia, multiple sclerotic seg-
ments, need for venovenostomy, or vein patch angio-
plasty. All composite and arm vein grafts were considered
poor quality conduit. Grafts were routinely dilated with
a heparin/papaverine hydrochloride solution (60 mg
papaverine hydrochloride, 5000 U heparin, and 0.9 N
saline). Angioscopy and valve lysis was regularly employed
with the in situ technique and selectively in cases using
nonsaphenous vein.
All patients were treated with preoperative antiplatelet
therapy (aspirin typically unless a confirmed allergy existed
and then an alternative agent was employed) and, as prac-
tice evolved, patients were routinely placed on postopera-
tive statin therapy, if not already chronically treated. Post-
operative anticoagulation with warfarin was continued in
patients who were so treated preoperatively. Anticoagula-
tion was initiated at the operating surgeon’s discretion
based on his/her assessment of the likelihood of graft
failure based on the intraoperative assessment of conduit
and target artery quality and/or CDU results. It is standard
practice within our group to perform completion imaging
(CDU or arteriography), and to anticoagulate crural level
bypasses only when no technical errors are apparent and
bypasses are believed to be “disadvantaged” (ie, at high risk
for failure). Such bypasses are those with poor conduit or
poor target arteries with poor runoff or with low EDV.
Poor target/runoff arteries were defined as arteries requir-
ing thromboendarterectomy at time of bypass, inability to
accommodate a 1-mm dilator, or isolated to the leg with Pnly discontinuous tarsal or plantar arteries at completion
rteriography.
Intraoperative duplex scanning was performed by sur-
eons using a low-profile, 10-MHz linear array transducer
Entos CL 10-5: ATL; Philips ATL, Bothell, Wash). A
ertified vascular technologist was present during each ex-
mination. High-resolution color Doppler images and cen-
er stream velocity spectra at a Doppler angle-corrected
can of 60 degrees relative to the vessel wall were obtained.
mages of each vein graft were taken proximal to distal and
ncluded the entire graft, anastomoses, and adjacent native
rteries. Longitudinal and transverse images were acquired
o elucidate luminal defects, turbulent blood flow, and
raft hemodynamics. Hemodynamic variables such as PSV,
DV, and resistive indexes (RI PSV EDV/PSV) were
ecorded at each anastomosis, within the native outflow
rtery, and in the proximal and distal graft.
Technical adequacy of bypasses was verified by absence
f retained valves, localized velocity step-ups, or arterio-
enous fistulae and presence of graft-dependent pedal
ulses.
Preoperative arteriograms were reviewed in all cases to
ssess distal popliteal and tibial runoff and scored according
o modified Society for Vascular Surgery criteria for all
essels such that a higher score implies worse runoff (min-
mum 1 and maximum 19). The validation and description
f this scoring system has been previously reported.9-12
hose scoring arteriograms had no knowledge of the pa-
ients’ outcomes or EDVs.
Postoperative graft surveillance included duplex ultra-
ound and segmental limb pressure measurements per-
ormed at 1 month and approximately 3-month intervals in
he first postoperative year in all patients. In the second
ear, all patients underwent duplex examination at least
emiannually. Afterward, patients were followed with an-
ual examinations. Vein grafts were considered at risk for
hrombosis if, at postoperative duplex, a 3.5 step-up in
SV was discovered particularly if accompanied by a 0.15
eduction in ankle-brachial index. Patency was determined
rom the date of initial operation to the date of thrombosis
ecorded on a duplex image or the first documented onset
f ischemic symptoms. Thrombosis was verified on the
urveillance graft duplex scan if no flow was documented
ithin the graft.
Because graft thrombosis was the clinical end point of
nterest, primary-assisted patency was used as the primary
utcome measure. Statistical analysis was performed of
atient demographics and bypass characteristics of all grafts
sing 2. Kaplan-Meier and life table methodology (ana-
yzed at 1-month intervals) were used to determine primary
ssisted patency and limb salvage and were reported at 1
ear. Differences between groups were determined using
he log-rank test. Predictors of low distal graft EDV and
rimary assisted patency were determined by multivariate
ogistic and Cox proportional-hazards regressions. We con-
idered for inclusion in the multivariate models variables
ith a univariate relationship with the outcome measure of
 .20. Interactions between covariates were tested and
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October 20111008 Scali et almodeled appropriately with interaction terms. Parsimony
was achieved in a backward stepwise fashion such that the
final multivariable models contained only those variables
with a relationship of P  .05. Data were analyzed using
Stata (College Station, Tex).
RESULTS
From 1998 to 2008, 1033 infragenicular revasculariza-
tions were completed at Dartmouth-Hitchcock Medical
Center. Four hundred twelve primary crural bypass grafts
were identified using either autologous or prosthetic con-
duit for debilitating claudication, rest pain, or tissue loss. Of
these, 138 (33%) were performed in patients who under-
went primary tibial level arterial reconstruction with autog-
enous vein and a completion graft duplex. One hundred
sixteen grafts (84%) had complete data sets with follow-up.
These comprise the study cohort. All of these patients
suffered rest pain (34%) or tissue loss (66%). Mean
follow-up was 1.4  1.5 years (median, 0.86 years). Sev-
enty (60%) cases were performed by two authors (E.R.M.,
D.B.W.) who routinely performCDU, while the remaining
cases were performed using an identical protocol by mem-
bers of the Section of Vascular Surgery who apply CDU at
need but not routinely. At bypass completion, 74 (64%)
patients had a single patent tibial vessel compared with 31
(26%) with two-vessel runoff and 11 (10%) with three-
vessel patency below the knee. All veins were considered
adequate at preoperative vein mapping. Thirty-nine veins
used for bypass conduit (33.6%) were considered to be
poor quality by surgeon assessment at operation. Sixteen of
these 39 bypasses employed arm vein. Twenty-seven patients
(22.4%) were found to have poor runoff. No residual he-
modynamic or anatomic abnormalities remained at case
completion in any graft included in this study. Twenty-
eight (24%) patients were treated with warfarin anticoagu-
lation after surgery either because patients were anticoagu-
lated prior to surgery for chronic medical indications or
because the operating surgeon decided the graft was “dis-
advantaged” at surgery.
Overall patency. Primary, primary-assisted, and sec-
ondary patency of the bypasses was 62%, 66%, 70%, respec-
tively, at 12 months (Table I). When stratified by distal
graft EDV (5-cm/s, n  28; 5-15 cm/s, n  56;
and15 cm/s, n 32), the observed 1 year patencies were
Table I. One-year bypass patency stratified by distal graft
end-diastolic velocity (EDV)
EDV category Primary
Primary-
assisted Secondary
EDV 15 cm/s (28a) 84% 88% 88%
EDV 5–15 cm/s (41a) 64% 70% 72%
EDV  5 cm/s (22a) 32% 32% 38%
P value .04 .001 .003
Standard error  10% for reported interval.
aNumber of grafts available for analysis during first year.primary, 32% (5cm/s), 64% (5-15 cm/s), and 84% (15 m/s) (P .04); primary-assisted, 32%, 70%, and 88% (P
001); and secondary, 38%, 72%, and 88% (P .003) Table I.
y univariate analysis of patient demographics and bypass
haracteristics, there were no significant associations be-
weenmajor vascular comorbidities, presence of rest pain or
issue loss, status of the inflow/outflow vessels and graft
hrombosis (loss of primary assisted patency). Patients
ounger than age 70 (P .02) or not on a statin (P .03)
nd veins deemed to be poor quality (P .04) or with a low
DU EDV (5 cm/s) (P  .001) were more frequently
ssociated with loss of primary assisted patency (Table II).
hile there was a trend toward improved primary patency
n patients on warfarin on univariate analysis (P  .06), it
as not associated with improved primary assisted patency
P  .33). Patients with low EDV were more likely to be
reated with warfarin postoperatively. Ten (36%) grafts in
he low-EDV group, 12 (21%) in the mid-EDV group, and
ix (18%) in the high-EDV group received warfarin after
evascularization. Modified Rutherford runoff score was
lso not associated with graft patency (0  0.58).
Predictors of graft thrombosis. Independent predic-
ors of primary assisted patency were determined using Cox
roportional-hazards regression. Low EDV (5 cm/s)
hazard ratio [HR], 3.3; confidence interval [CI], 1.7-6.4;
 .001), poor-quality vein (2.5; 1.2-5.2; P  .016), age
able II. Patient and bypass characteristics of patent and
hrombosed grafts
Patent Thrombosed P value
o. 74 42 N/A
ean age (years SEM) 71  4 68  3 .38
oung age (70) 31 27 .02
ale gender 50 29 .87
omorbidities
HTN 69 37 .34
CAD 50 29 .87
DM 44 23 .58
Smoking 52 28 .69
CRI (Cr 1.5) 17 8 .62
CHF 16 10 .78
Statin use 40 11 .03
ndication
Best pain 26 19 .32
Tissue loss 48 23 .28
nflow (artery)
Popliteal (AK/BK) 9 6 .78
Common femoral 42 22 .65
Profunda femoral 2 2 .62
Superficial femoral 19 14 .40
umber of outflow vessels
1 45 29 .38
2 22 9 .33
3 7 4 .99
oor outflow
Disadvantaged” conduit 26 23 .04
ow EDV (5 cm/s) 11 17 .001
K, Above-knee; BK, below-knee; CAD, coronary artery disease; CHF,
ongestive heart failure;DM, diabetes mellitus; EDV, end-diastolic velocity;
TN, hypertension;N/A, not applicable; SEM, standard error of the mean.70 years (2.1; 1.1-4.0; P  .031) were all significantly
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Volume 54, Number 4 Scali et al 1009associated with the loss of primary assisted patency (Table
III). Preoperative statin use was protective (0.49; 0.25-
0.96; P  .038). Although not associated with primary
assisted patency, warfarin therapy was weakly associated
with primary patency. On multivariate analysis, low EDV
(2.1; 1.2-3.8; P  .011) and poor vein quality (2.8; 1.0-
7.3; P  .041) were also predictive of loss of primary
patency; however, warfarin use was not (P  .34).
Predictors of low distal graft EDV. Patient comor-
bidities or bypass characteristics predictive of low EDV
were determined by multivariate logistic regression analy-
sis. Poor Rutherford runoff score (8) (odds ratio [OR],
7.2; CI, 1.3-38.8; P .049), single tibial vessel runoff (3.3;
1.1-9.7; P .027), poor-quality conduit (2.9; 1.2-7.4; P
.024), and diabetes (2.9; 1.1-7.2; P .025) were all found
to be independent predictors of a low distal graft EDV at
CDU (Table IV).
Low EDV and risk factors. Because patient-specific
factors and anatomic variables were found to be associated
with graft thrombosis, we sought to understand if these
interactions were additive. For example, if a patient was
found to have low distal graft EDV and either young age
(70) or a disadvantaged bypass or not on a statin, graft
patency was re-examined to elucidate the potential impact
of a specific risk factor with a low EDV. Grafts with low
EDV but no other risk factors had a primary-assisted pa-
tency of 73%. When any single risk factor was present with
low EDV, primary-assisted patency fell to 22% (P  .001)
(Fig).
DISCUSSION
Bypass success in patients with CLI has been shown to
positively impact survival (mean gain of 7.3 months) and
trends toward increased amputation-free survival.13 Thus, a
number of techniques have been employed to confirm the
Table III. Multivariate predictors of graft thrombosisa
HR CI P valueb
Low EDV 3.3 1.7–6.4 .001
Poor conduit 2.5 1.2–5.2 .016
Age 70 years 2.1 1.1–4.0 .031
Statin 0.51 0.25–0.96 .038
CI, Confidence interval; HR, hazard ratio.
aPrimary-assisted patency.
bCox proportional hazards regression.
Table IV. Multivariate predictors of low distal graft end-
diastolic velocity (EDV 5 cm/s)
OR CI P valuea
Single-vessel runoff 3.3 1.1–9.7 .027
Poor conduit 2.9 1.2–7.4 .024
Diabetes 2.9 1.1–7.2 .025
EDV, End-diastolic velocity.
aLogistic regression analysis.adequacy of newly constructed infrainguinal grafts. Con- ruit quality and type, as well as tibial runoff status have
een linked to outcome after crural revascularization.3 Also
reoperative and intraoperative vein graft duplex, visual
nspection, venography, and angioscopy have all been used
o determine adequacy of the conduit.
This analysis confirms that EDV at CDU is a powerful
redictor of crural bypass performance and is the first to
ssociate patient characteristics with EDV to identify pa-
ients at higher risk of postoperative graft thrombosis prior
o the procedure’s completion. A single risk factor (either
iabetes, lack of statin use, poor-quality conduit and young
ge [70]) and a distal graft EDV 5 cm/s resulted in
rimary and primary-assisted patencies of 21% and 22%,
espectively, at 1 year. We speculate these risk factors with
he exception of poor conduit are proxies for compromised
unoff. These represent physiological factors opposed to
he two-dimensional anatomic pictures provided by com-
letion arteriography.
Currently, our practice is to treat all patients with
erioperative statins and daily aspirin. If distal graft EDV
5 cm/s is obtained, on-table arteriography is performed
o identify opportunities to improve the vein graft or the
ibial target(s). Such maneuvers include changing or find-
ng additional or better-quality bypass targets, vein patch
ngioplasty to any narrow or sclerotic areas, or performing
distal arteriovenous fistula. In the event that no anatomic
roblem is found, we believe, as has been reported by
thers, anticoagulation with warfarin postoperatively is in-
icated.14,15
There are limitations inherent in this analysis. A ran-
omized, prospective validation of CDU would be neces-
ary to prove clinical benefit compared to hand-held Dopp-
er insonation and/or arteriography. Additionally, an
ssociation with amputation-free survival and limb salvage
ould strengthen the argument that CDU is an important
djunct to crural revascularization. With use of ultrasound,
ntraobserver variability is possible. However, there has not
een significant variation in results in our practice. Acqui-
ition of appropriate windows is straightforward given di-
ig. Primary-assisted patency stratified by end-diastolic velocity
EDV) ( other risk predictors).ect access to each graft and EDV is routinely recorded on
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that warfarin use has benefit in “disadvantaged” grafts, the
number of patients treated with warfarin after revascular-
ization in this series was too small and too evenly distrib-
uted among EDV groups to permit productive analysis.
Finally, overall primary patency at 3 years in the study
cohort was 44%. This may seem low compared with other
series. However, over half (56%) of the grafts were desig-
nated as being “disadvantaged” by the operating surgeon.
Considering this, these results compare favorably with sim-
ilar series.14 Additionally, 40% of the bypasses analyzed
were performed by surgeons who employed CDU only in
“difficult or compromised” cases to be included in this
study population.
CONCLUSION
Low EDV at CDU, particularly in combination with
diabetes, lack of statin use, poor-quality conduit, or young
age (70), predicts vein graft thrombosis in patients un-
dergoing crural revascularization for CLI. Stratification of
patient anatomic, metabolic, and intraoperative physiolog-
ical parameters such as EDV may help surgeons select
patients in whom additional maneuvers at operation,
chronic anticoagulation, and aggressive postoperative sur-
veillance may improve bypass performance. At least, this
information may provide surgeons, patients, and their fam-
ilies with important prognostic information.
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